Do most patients with obesity or type 2 diabetes, and atrial fibrillation, also have undiagnosed heart failure? A critical conceptual framework for understanding mechanisms and improving diagnosis and treatment-Reference-Cited by-同舟云学术

Do most patients with obesity or type 2 diabetes, and atrial fibrillation, also have undiagnosed heart failure? A critical conceptual framework for understanding mechanisms and improving diagnosis and treatment

Published:2020-02 Issue:2 Volume:22 Page:214-227
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Packer Milton¹²

Affiliation:

1. Baylor Heart and Vascular Institute, Baylor University Medical Center Dallas TX USA

2. Imperial College London London UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1646

Reference255 articles.

1. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction

3. Heart Failure: The Most Important, Preventable, and Treatable Cardiovascular Complication of Type 2 Diabetes

4. Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus

5. Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth differentiation factor 15 alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathy;Cell Reports;2024-08

2. Exploring the power of photoplethysmogram matrix for atrial fibrillation detection with integrated explainability;Engineering Applications of Artificial Intelligence;2024-07

3. Global epidemiology of heart failure;Nature Reviews Cardiology;2024-06-26

4. Identification of molecular signatures in epicardial adipose tissue in heart failure with preserved ejection fraction;ESC Heart Failure;2024-03-08

5. Heart failure with preserved ejection fraction: everything the clinician needs to know;The Lancet;2024-03